WHO ICTRP trial
A randomized, open-label, parallel-controlled phase III clinical trial of 5-dose…
ChiCTR2200061926 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200061926 |
|---|---|
| Public title | A randomized, open-label, parallel-controlled phase III clinical trial of 5-dose immunization schedule and 4-dose immunization schedule (2 doses for the first injection) of freeze-dried human rabies vaccine (Vero cells) in healthy people aged 10 to 50 years old supplementary research |
| Scientific title | A randomized, open-label, parallel-controlled phase III clinical trial of 5-dose immunization schedule and 4-dose immunization schedule (2 doses for the first injection) of freeze-dried human rabies vaccine (Vero cells) in healthy people aged 10 to 50 years old supplementary research |
| Primary sponsor | Hubei Provincial Center for Disease Control and Prevention |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 3 |
| Countries | China |
| Conditions | rabies |
| Interventions | Group 1 :rabies vaccine with 5 injections at day 0, 3, 7, 14, 28;Group 2:rabies vaccine with 4 injections at day 0 (twice a day), 7, 21;Group 3:rabies vaccine with 5 injections at day 0, 3, 7, 14, 28 |
| Registration date | Jul 11, 2022 |
| Target size | Group 1 :120;Group 2:120;Group 3:120 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: